Weekend Edition Saturday
<iframe src="http://www.npr.org/player/embed/829633/829634" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Documents filed in a federal lawsuit against Parke Davis shed more light on allegations that the drug manufacturer marketed the anti-seizure drug Neurontin for various unauthorized uses. NPR's Snigdha Prakash reports.
NPR thanks our sponsors
Become an NPR sponsor